Literature DB >> 19360438

beta(III)-tubulin at the invasive margin of colorectal cancer: possible link to invasion.

A Portyanko1, P Kovalev, J Gorgun, E Cherstvoy.   

Abstract

Cell locomotion, including cancer cell invasion, is closely associated with the dynamics of cytoskeletal structures. Previous in vitro studies indicated that tubulin isotype composition may affect polymerization properties and dynamics of microtubules. Colorectal cancer is a good model for studying tumour invasion because of the easily detectable invasive front. Hence, we investigated the localization of beta(III)-tubulin in colorectal cancer specimens. Immunohistochemical staining for beta(III)-tubulin was evident in cancer cells apparently budding from adjacent malignant cells with a higher differentiation and negative staining. An association between beta(III)-tubulin immunoreactivity and tumour budding grade was demonstrated. To the best of our knowledge, this is the first report documenting a preferential localization of beta(III)-tubulin in the invading epithelium. From this finding arises the possibility that changes in tubulin isotypes could modulate the invading activity of cancer cells. Further investigations are needed to determine whether our findings have clinical implications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19360438     DOI: 10.1007/s00428-009-0764-4

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  29 in total

1.  Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.

Authors:  M Kavallaris; D Y Kuo; C A Burkhart; D L Regl; M D Norris; M Haber; S B Horwitz
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Interactions of a bicyclic analog of colchicine with beta-tubulin isoforms alphabeta(II), alphabeta(III) and alphabeta(IV).

Authors:  A Banerjee; Y Engelborghs; A D'Hoore; T J Fitzgerald
Journal:  Eur J Biochem       Date:  1997-06-01

3.  Increased microtubule assembly in bovine brain tubulin lacking the type III isotype of beta-tubulin.

Authors:  A Banerjee; M C Roach; P Trcka; R F Ludueña
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

4.  Differential localization of class III, beta-tubulin isotype and calbindin-D28k defines distinct neuronal types in the developing human cerebellar cortex.

Authors:  C D Katsetos; A Frankfurter; S Christakos; E L Mancall; I N Vlachos; H Urich
Journal:  J Neuropathol Exp Neurol       Date:  1993-11       Impact factor: 3.685

5.  Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

Authors:  H Ueno; J Murphy; J R Jass; H Mochizuki; I C Talbot
Journal:  Histopathology       Date:  2002-02       Impact factor: 5.087

6.  Interaction of estramustine with tubulin isotypes.

Authors:  N Laing; B Dahllöf; B Hartley-Asp; S Ranganathan; K D Tew
Journal:  Biochemistry       Date:  1997-01-28       Impact factor: 3.162

7.  Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells.

Authors:  S Ranganathan; C A Benetatos; P J Colarusso; D W Dexter; G R Hudes
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

8.  Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma.

Authors:  Takashi Okuyama; Masatoshi Oya; Hiroshi Ishikawa
Journal:  J Surg Oncol       Date:  2003-05       Impact factor: 3.454

Review 9.  Class III beta-tubulin in human development and cancer.

Authors:  Christos D Katsetos; Mary M Herman; Sverre J Mörk
Journal:  Cell Motil Cytoskeleton       Date:  2003-06

10.  Expression of beta-tubulin isotypes in human primary ovarian carcinoma.

Authors:  Yoshihiro Ohishi; Yoshinao Oda; Yuji Basaki; Hiroaki Kobayashi; Norio Wake; Michihiko Kuwano; Masazumi Tsuneyoshi
Journal:  Gynecol Oncol       Date:  2007-03-06       Impact factor: 5.482

View more
  18 in total

1.  Up-regulation of hnRNP A1, Ezrin, tubulin β-2C and Annexin A1 in sentinel lymph nodes of colorectal cancer.

Authors:  Zhen-Yu He; Hao Wen; Chuan-Bing Shi; Jie Wang
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

2.  Anti-MTOC-MT antibody is commonly detected by AIT test in colorectal cancer patients.

Authors:  Jung-Uk Sir; Think-You Kim
Journal:  Virchows Arch       Date:  2009-06-10       Impact factor: 4.064

Review 3.  Microtubules and resistance to tubulin-binding agents.

Authors:  Maria Kavallaris
Journal:  Nat Rev Cancer       Date:  2010-02-11       Impact factor: 60.716

4.  ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients.

Authors:  Lsabel Hostettler; Inti Zlobec; Luigi Terracciano; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

5.  Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

6.  Expression of β-tubulin isotypes in urothelial carcinoma of the bladder.

Authors:  Jung-Woo Choi; Younghye Kim; Ju-Han Lee; Young-Sik Kim
Journal:  World J Urol       Date:  2012-11-27       Impact factor: 4.226

7.  Tubulin Beta 2C Chain (TBB2C), a Potential Marker of Ovarian Cancer, an Insight from Ovarian Cancer Proteome Profile.

Authors:  Shahzadi Noreen; Safa Akhtar; Tahira Batool; Qurratulann Afza Gardner; Muhammad Waheed Akhtar
Journal:  ACS Omega       Date:  2021-04-13

Review 8.  Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  Oncotarget       Date:  2010-11

Review 9.  The Role of Microtubules in Pancreatic Cancer: Therapeutic Progress.

Authors:  Mugahed Abdullah Hasan Albahde; Bulat Abdrakhimov; Guo-Qi Li; Xiaohu Zhou; Dongkai Zhou; Hao Xu; Huixiao Qian; Weilin Wang
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

10.  Thymosin ß4 expression in colorectal polyps and adenomas.

Authors:  Sonia Nemolato; Tiziana Cabras; Angelo Restivo; Luigi Zorcolo; Eliana Di Felice; Daniela Fanni; Clara Gerosa; Irene Messana; Massimo Castagnola; Gavino Faa; Giuseppe Casula
Journal:  Clinics (Sao Paulo)       Date:  2013-09       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.